SBIR/STTR Research Award

Development of a charge-sensitive optical detection system for high-throughput study of small molecules

Award identifier 8577d44ecc0a2f7c96005280f8e17e977302a44db036024be6b58fceea58975bAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$1,669,264

Program and phase

SBIR · Phase II – Direct to Phase II

Award year

2021

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
BIOSENSING INSTRUMENT INC
Proposal award date
2021-05-18
Contract end date
2023-03-31
UEI
RCL7B2TBY9H9
Solicitation number
PA20-260
Topic code
400

Research abstract

TITLE: Development of a charge sensitive optical detection system for high-throughput study of small molecules SUMMARY Measuring the kinetics of small molecule binding to protein receptors and biochemical reactions of proteins, such as post-translational protein modifications, is a basic task in the understanding of diseases, discovering of diagnosis biomarkers, and screening of drugs. Various label-free techniques have been developed, but their sensitivity decreases with the molecular mass, which makes it challenging to detect small molecules and biochemical reactions. A charge sensitive optical detection (CSOD) system is proposed to address this unmet need. The technology is not only sensitive to small molecules, but also compatible with the standard microplate technology, which is particularly suitable for high-throughput applications. The working principle was established and validated with the support of NIH NCI IMAT (Innovative Molecular Analysis Technologies for cancer research) grants (R21 and R33) to the Arizona State University (ASU) team. In this SBIR direct phase II project, Biosensing Instrument Inc. (BI) will work with the ASU team to develop a commercially viable prototype system. We will continue collaborations with potential customers in biomedical research and pharmaceutical industries for testing samples relevant to their interest and validating the performance usability of the developing system.The success of the project will lead to a new high-throughput screening technology for measuring molecular interactions, particularly small molecule interactions with proteins, and post-translational modifications of proteins. These processes are highly important for biomarker discovery, disease diagnosis and drug screening.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

12 SBIR/STTR records share this UEI (2013–2025). Reported award amounts total $11,166,010. Reported amounts are not federal obligations.

Phases: Phase I, Phase II, Phase II – Direct to Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.